Log In
Print this Print this

atacicept (formerly TACI-Ig)

  Manage Alerts
Collapse Summary General Information
Company Bristol-Myers Squibb Co.
DescriptionRecombinant fusion protein containing the soluble TACI receptor that binds to BLyS (BAFF) and tumor necrosis factor (TNF) ligand superfamily member 13 (TNFSF13; APRIL)
Molecular Target BLyS (BAFF) ; Tumor necrosis factor (TNF) ligand superfamily member 13 (TNFSF13) (APRIL)
Mechanism of Action 
Therapeutic ModalityBiologic: Fusion protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today